Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management

SYC Tong, JS Davis, E Eichenberger… - Clinical microbiology …, 2015 - Am Soc Microbiol
Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

[HTML][HTML] Are coagulase-negative staphylococci virulent?

C Heilmann, W Ziebuhr, K Becker - Clinical Microbiology and Infection, 2019 - Elsevier
Background Progress in contemporary medicine is associated with an increasing number of
immunocompromised individuals. In this vulnerable group, the underlying disease together …

All-Cause and Infection-Related Mortality in Staphylococcus aureus Bacteremia, a Multicenter Prospective Cohort Study

TW van der Vaart, JM Prins… - Open forum …, 2022 - academic.oup.com
Background Staphylococcus aureus bacteremia (SAB) is a heterogeneous disease with
changing epidemiology due to changing demographics and evolving clinical management …

Staphylococcus aureus bacteremia and endocarditis

CA Petti, VG Fowler - Infectious Disease Clinics, 2002 - id.theclinics.com
Staphylococcus aureus is a leading cause of bacteremia and endocarditis. Over the past
several years, the frequency of S. aureus bacteremia (SAB) has increased dramatically. This …

Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes

VH Chu, DR Crosslin, JY Friedman, SD Reed… - The American journal of …, 2005 - Elsevier
PURPOSE: Although Staphylococcus aureus is a leading cause of nosocomial infection,
little is known about the impact of S. aureus bacteremia on patients with prosthetic devices …

Methicillin-resistant Staphylococcus aureus prosthetic valve endocarditis: pathophysiology, epidemiology, clinical presentation, diagnosis, and management

A Galar, AA Weil, DM Dudzinski, P Muñoz… - Clinical microbiology …, 2019 - Am Soc Microbiol
Staphylococcus aureus prosthetic valve endocarditis (PVE) remains among the most morbid
bacterial infections, with mortality estimates ranging from 40% to 80%. The proportion of …

Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA

RV Rasmussen, VG Fowler Jr, R Skov… - Future …, 2011 - Taylor & Francis
Staphylococcus aureus bacteremia (SAB) is an urgent medical problem due to its growing
frequency and its poor associated outcome. As healthcare delivery increasingly involves …

The many faces of Staphylococcus aureus infection: Recognizing and managing its life-threatening manifestations

JJ Weems Jr - Postgraduate medicine, 2001 - Taylor & Francis
PREVIEW As the incidence of serious Staphylococcus aureus infection continues to
increase in developed nations, physicians must search for answers—not just about how the …

Staphylococcus aureus Bacteremia: Epidemiology, Pathophysiology, and Management Strategies

CK Naber - Clinical infectious diseases, 2009 - academic.oup.com
Staphylococcus aureus is a major cause of bacteremia, and S. aureus bacteremia is
associated with higher morbidity and mortality, compared with bacteremia caused by other …

Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

SYC Tong, LF Chen, VG Fowler - Seminars in immunopathology, 2012 - Springer
Staphylococcus aureus is a human commensal that can also cause a broad spectrum of
clinical disease. Factors associated with clinical disease are myriad and dynamic and …